Advertisement

Management of Ventilator-associated Pneumonia

  • M. Ferrer
  • M. Valencia
  • A. Torres
Conference paper

Abstract

Pneumonia is the most important respiratory infection in mechanically ventilated patients. It is defined as the presence of microorganisms in the pulmonary parenchyma leading to the development of an inflammatory response by the host, which may be localized in the lung or may extend systemically. Nosocomial pneumonia is an infectious process which develops within 48 hours after admission to the hospital and that was not incubating at the time of hospitalization. Ventilator-associated pneumonia (VAP) is considered as a subgroup of nosocomial pneumonia and is an infectious pulmonary process which develops 48 hours after the presence of an artificial airway and mechanical ventilation. Since a large proportion of the patients who develop nosocomial pneumonia are intubated and receive mechanical ventilation, most epidemiological and clinical studies on nosocomial pneumonia have been focused on critically ill patients and those receiving mechanical ventilation. From a clinical point of view, nosocomial pneumonia is of great importance not only because of the consequences of the important morbidity and mortality but also due to the high costs associated with development of this disease.

Keywords

Mechanical Ventilation Respir Crit Nosocomial Pneumonia Stress Ulcer Prophylaxis Clinical Pulmonary Infection Score 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Langer M, Cigada M, Mandelli M, Mosconi P, Tognoni G (1987) Early-onset pneumonia: a multicenter study in intensive care units. Intensive Care Med 13:342–346PubMedCrossRefGoogle Scholar
  2. 2.
    Vincent JL, Bihari DJ, Suter PM, et al (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 274:639–644PubMedCrossRefGoogle Scholar
  3. 3.
    Prod’hom G, Leuenberger P, Koerfer J, et al (1994) Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. Ann Intern Med 120:653–662Google Scholar
  4. 4.
    Torres A, Aznar R, Gatell JM, et al (1990) Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 142:523–528PubMedGoogle Scholar
  5. 5.
    Sopena N, Sabriá M, and the Neunos Study group (2005) Multicenter study of hospitalacquired pneumonia in non-ICU patients. Chest 127:213–219PubMedCrossRefGoogle Scholar
  6. 6.
    Langer M, Mosconi P, Cigada M, Mandelli M (1989) Long-term respiratory support and risk of pneumonia in critically ill patients. Intensive Care Unit Group of Infection Control. Am Rev Respir Dis 140:302–305PubMedGoogle Scholar
  7. 7.
    Fagon JY, Chastre J, Domart Y, et al (1989) Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 139:877–884PubMedGoogle Scholar
  8. 8.
    Cook DJ, Walter SD, Cook RJ, et al (1998) Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 129:433–440PubMedGoogle Scholar
  9. 9.
    Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR (1986) Risk factors for pneumonia and fatality in patients receiving mechanical ventilation. Am Rev Respir Dis 133:792–796PubMedGoogle Scholar
  10. 10.
    Kollef MH (1993) Ventilator-associated pneumonia: A multivariate analysis. JAMA 270:1965–1970PubMedCrossRefGoogle Scholar
  11. 11.
    Lossos IS, Breuer R, Or R, et al (1995) Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 60:672–678PubMedCrossRefGoogle Scholar
  12. 12.
    Antonelli M, Moro ML, Capelli O, et al (1994) Risk factors for early-onset pneumonia in trauma patients. Chest 105:224–228PubMedCrossRefGoogle Scholar
  13. 13.
    Cardenosa Cendrero JA, Sole-Violan J, Bordes Benitez A, et al (1999) Role of different routes of tracheal colonization in the development of pneumonia in patients receiving mechanical ventilation. Chest 116:462–470Google Scholar
  14. 14.
    Johanson WG, Pierce AK, Sanford JP, Thomas GD (1972) Nosocomial respiratory infection with Gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med 77:701–706PubMedGoogle Scholar
  15. 15.
    Estes RJ, Meduri GU (1995) The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonization and airway inoculation. Intensive Care Med 21:365–383PubMedCrossRefGoogle Scholar
  16. 16.
    Garrouste-Orgeas M, Chevret S, Arlet G, et al (1997) Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA analysis. Am J Respir Crit Care Med 156:1647–1655PubMedGoogle Scholar
  17. 17.
    Rello J, Sonora R, Jubert P, Artigas A, Rue M, Valles J (1996) Pneumonia in intubated patients: Role of respiratory airway care. Am J Respir Crit Care Med 154:111–115PubMedGoogle Scholar
  18. 18.
    Sirvent JM, Torres A, El-Ebiary M, Castro P, de Batlle J, Bonet A (1997) Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am J Respir Crit Care Med 155:1729–1734PubMedGoogle Scholar
  19. 19.
    Rello J, Ausina V, Ricart M, Castella J, Prats G (1993) Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 104:1230–1235PubMedCrossRefGoogle Scholar
  20. 20.
    Trouillet JL, Chastre J, Vuagnat A, et al (1998) Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am Rev Respir Dis 157:531–539Google Scholar
  21. 21.
    Torres A, Serra-Batlles J, Ros E, et al (1992) Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 116:540–543PubMedGoogle Scholar
  22. 22.
    Orozco-Levi M, Torres A, Ferrer M, et al (1995) Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients. Am J Respir Crit Care Med 152:1387–1390PubMedGoogle Scholar
  23. 23.
    Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer M (1999) Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 354:1851–1858PubMedCrossRefGoogle Scholar
  24. 24.
    Tryba M (1987) Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care patients: Sucralfate versus antacids. Am J Med 83:117–124PubMedCrossRefGoogle Scholar
  25. 25.
    Cook D, Guyatt G, Marshall J, et al (1998) A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 338:791–797PubMedCrossRefGoogle Scholar
  26. 26.
    Messori A, Tripoli S, Vaiani M, et al (2003) Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ 32:1103–1106Google Scholar
  27. 27.
    Fabregas N, Ewig S, Torres A, et al (1999) Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 54: 867–873PubMedCrossRefGoogle Scholar
  28. 28.
    Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter P (1991) Diagnosis of ventilator associated pneumonia by bacteriologic analysis of bronchoscopic and non-bronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis 143:1121–1129PubMedGoogle Scholar
  29. 29.
    Fartoukh M, Maitre B, Honore S, et al (2003) Diagnosing pneumonia during mechanical ventilation: The clinical pulmonary infection score revisited. Am J Respir Crit Care Med 168: 173–179PubMedCrossRefGoogle Scholar
  30. 30.
    Ioanas M, Ferrer M, Angrill J, Ferrer M, Torres A (2001) Microbial investigation on vetilatorassociated pneumonia. Eur Respir J 17:791–801PubMedCrossRefGoogle Scholar
  31. 31.
    Valencia M, Torres A, Insausti J, et al (2003) Valor diagnóstico del cultivo cuantitativo del aspirado endotraqueal en la neumonía adquirida durante la ventilación mecánica. Estudio multicéntrico. Arch Bronconeumol 39:394–399CrossRefGoogle Scholar
  32. 32.
    Torres A, Puig de la Bellacasa J, Xaubet A, et al (1989) Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia. Am Rev Respir Dis 140:306–310Google Scholar
  33. 33.
    Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, et al (1998) Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med 157:371–376PubMedGoogle Scholar
  34. 34.
    Sole-Violan J, Fernandez JA, Benitez AB, Cardenosa Cendrero JA, Rodriguez de Castro F (2000) Impact of quantitative invasive diagnostic techniques in the management of outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med 28:2737–2741Google Scholar
  35. 35.
    Ruiz M, Torres A, Ewig S, et al (2000) Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 162:119–125PubMedGoogle Scholar
  36. 36.
    Fagon JY, Chastre J, Wolff M, et al (2000) Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. Ann Intern Med 132:621–630PubMedGoogle Scholar
  37. 37.
    Torres A, Ewig S (2004) Diagnosing ventilator-associated pneumonia. N Engl J Med 350: 433–435PubMedCrossRefGoogle Scholar
  38. 38.
    Alvarez-Lerma F (1996) Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-acquired Pneumonia Study Group. Intensive Care Med 22:387–394PubMedCrossRefGoogle Scholar
  39. 39.
    Luna CM, Vujacich P, Niederman MS, et al (1997) Impact of BAL data on therapy and outcome of ventilator-associated pneumonia. Chest 111:676–687PubMedCrossRefGoogle Scholar
  40. 40.
    Rello J, Diaz E (2003) Pneumonia in the intensive care unit. Crit Care Med 31:2544–2551PubMedCrossRefGoogle Scholar
  41. 41.
    Kollef MH, Ward S (1998) The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 113:412–420PubMedCrossRefGoogle Scholar
  42. 42.
    Rello J, Gallego M, Mariscal D, Sonora R, Valles J (1997) The value of routine microbiologic investigation in the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 156:196–200PubMedGoogle Scholar
  43. 43.
    American Thoracic Society (1996) Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement. Am J Respir Crit Care Med 153:1711–1725Google Scholar
  44. 44.
    Ioanas M, Cavalcanti M, Ferrer M, et al (2003) Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines. Eur Respir J 22:876–882PubMedCrossRefGoogle Scholar
  45. 45.
    Niederman M, Craven D (2005) Guidelines for the management of adults with hospitalacquired pneumonia, ventilator-associated pneumonia, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRefGoogle Scholar
  46. 46.
    Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR (1989) Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 87:540–546PubMedCrossRefGoogle Scholar
  47. 47.
    Korvick JA, Bryan CS, Farber B, et al (1992) Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother 36:2639–2644PubMedGoogle Scholar
  48. 48.
    Chastre J, Wolff M, Fagon JY, et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290:2588–2598PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media Inc. 2008

Authors and Affiliations

  • M. Ferrer
    • 1
  • M. Valencia
    • 1
  • A. Torres
    • 1
  1. 1.Pulmonology ServiceInstitut Clinic del Torax Hospital ClinicBarcelonaSpain

Personalised recommendations